MedTrace Logo

Lidocaine Infusion for Postthoracotomy Pain Syndrome

NCT03666299 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2018-11-07

No results posted yet for this study

Summary

This study seeks to investigate lidocaine infusion to reduce postthoractomy pain syndrome after thoracic Surgery

Conditions

  • Thoracic Surgery, Video-Assisted
  • Lidocaine
  • Pain, Postoperative
  • Chronic Pain

Interventions

DRUG

Lidocaine

Infusion of 2% lidocaine hydrochloride at 4 mL/h, started after tracheal intubation and discontinued until 24 h after surgery.

DRUG

Control

Infusion of normal saline at 4 mL/h, started after tracheal intubation and discontinued until 24 h after surgery.

Sponsors & Collaborators

  • Guangzhou First People's Hospital

    lead OTHER

Principal Investigators

  • Xiangcai Ruan, PhD · Affliated First People's Hospital of Guangzhou ,Guangzhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-06
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03666299 on ClinicalTrials.gov